Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dense Breasts”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Not applicableWithdrawnNCT03616457
What this trial is testing

Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynthesis

Who this might be right for
Breast Cancer
GE Healthcare
Testing effectiveness (Phase 2)Study completedNCT00394251
What this trial is testing

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Celgene 197
Not applicableLooking for participantsNCT05667532
What this trial is testing

The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,000
Testing effectiveness (Phase 2)Study completedNCT04224922
What this trial is testing

Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Universitair Ziekenhuis Brussel 63
Testing effectiveness (Phase 2)Study completedNCT00591851
What this trial is testing

Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 70
Not applicableActive Not RecruitingNCT04854304
What this trial is testing

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Who this might be right for
Breast Diseases
Abramson Cancer Center at Penn Medicine 500
Not applicableStudy completedNCT01588834
What this trial is testing

Histology of Functional Density in Premenopausal Breast

Who this might be right for
Dense BreastsBreast Cancer
Mayo Clinic 23
Not applicableActive Not RecruitingNCT05797545
What this trial is testing

Comparison of Ultrasound and Breast MRI for Breast Cancer Detection

Who this might be right for
Breast NeoplasmsBreast Cancer
Samsung Medical Center 1,756
Not applicableLooking for participantsNCT07505797
What this trial is testing

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Who this might be right for
Breast CancerBenign Breast ConditionBreast Fibroadenoma+6 more
iSono Health, Inc. 800
Not applicableUnknownNCT03033030
What this trial is testing

Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial

Who this might be right for
Breast Cancer
University of Genova 8,000
Not applicableStudy completedNCT03972605
What this trial is testing

Delphinus SoftVue™ ROC Reader Study

Who this might be right for
Breast Cancer DetectionDense Breast ParenchymaBenign Breast Findings+2 more
Delphinus Medical Technologies, Inc. 32
Large-scale testing (Phase 3)UnknownNCT01378533
What this trial is testing

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 100
Testing effectiveness (Phase 2)Study completedNCT00256360
What this trial is testing

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 117
Not applicableStudy completedNCT00991263
What this trial is testing

Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 3,677
Early research (Phase 1)Study completedNCT00107094
What this trial is testing

Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Celgene Corporation 30
Very early researchStudy completedNCT00722059
What this trial is testing

Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography

Who this might be right for
Breast NeoplasmsBreast Abnormalities
University of Michigan 50
Testing effectiveness (Phase 2)Study completedNCT00751868
What this trial is testing

FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC

Who this might be right for
Breast Cancer
Consorzio Oncotech 47
Testing effectiveness (Phase 2)UnknownNCT00496795
What this trial is testing

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer

Who this might be right for
Stage III Breast Cancer AJCC V7
University of Bergen 100
Testing effectiveness (Phase 2)Study completedNCT00201708
What this trial is testing

Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 56
Not applicableUnknownNCT02209389
What this trial is testing

OctavaPink for Women With Dense Breast After Negative Mammography

Who this might be right for
Breast Cancer
Eventus Diagnostics Ltd 1,750
Next Page